Angela A. Vitali

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Marc G. Achen, Michael Jeltsch, Eola Kukk et al. · Proceedings of the National Academy of Sciences · 1998 · 1.2K citations

Life Sciences, Bioinformatics, Molecular Biology +15

Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers

Steven A. Stacker, Kaye L. Stenvers, Carol Caesar et al. · Journal of Biological Chemistry · 1999 · 329 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1

Lyn M. Wise, Tanja Veikkola, Andrew A. Mercer et al. · Proceedings of the National Academy of Sciences · 1999 · 272 citations

Life Sciences, Infectious Diseases, Pathobiology +17

A Mutant Form of Vascular Endothelial Growth Factor (VEGF) That Lacks VEGF Receptor-2 Activation Retains the Ability to Induce Vascular Permeability

Steven A. Stacker, Angela A. Vitali, Carol Caesar et al. · Journal of Biological Chemistry · 1999 · 105 citations · Full text

Life Sciences, Developmental Biology, Cell Signaling +14

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478

Terrance G. Johns, Rodney B. Luwor, Carmel Murone et al. · Proceedings of the National Academy of Sciences · 2003 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14